maj 29, 2023

CCT251545 Analogue, Compound 51

CCT251545 Analogue, Compound 51 

To Order Contact us: bjorn@lembcke.dk

INCB024360 analogue

A3493-5.1 10 mM (in 1mL DMSO)
EUR 181.2
Description: INCB024360 analogue is a potent and selective inhibitor of IDO1 with IC50 value of 67 nM. [1]IDO (indoleamine-pyrrole 2, 3-dioxygenase) is an enzyme which is encoded by the IDO1 gene.

INCB024360 analogue

A3493-50 50 mg
EUR 498
Description: INCB024360 analogue is a potent and selective inhibitor of IDO1 with IC50 value of 67 nM. [1]IDO (indoleamine-pyrrole 2, 3-dioxygenase) is an enzyme which is encoded by the IDO1 gene.

GLPG0634 analogue

B6116-5 5 mg
EUR 375.6
Description: GLPG0634 is a potent and selective inhibitor of JAK1 with IC50 values of 10, 28, 810 and 116 nM for JAK1, JAK2, JAK3 and TYK2, respectively [1]. Janus kinase 1 (JAK1) is a member of the JAK family and is a non-receptor tyrosine kinase.

Pilaralisib analogue

HY-11105 10mM/1mL
EUR 165.6

Phentolamine Analogue 1

HY-U00404 5mg
EUR 1052.4

Analogue Vortex Mixer

MIX6700 EACH
EUR 547.2

Compound CL0485

ADC-P-074 unit Ask for price

Compound W

A4401-50 50 mg
EUR 212.4
Description: Inhibitor of ?-secretase; causes a decrease in the released levels of A?42 and notch-1 A?-like peptide 25 (N?25).

Compound 56

A8197-.5 500 µg
EUR 129.6
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM.

Compound 56

A8197-5 5 mg
EUR 268.8
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM.

Compound 56

A8197-5.1 10 mM (in 1mL DMSO)
EUR 324
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM.

Compound 56

A8197-S Evaluation Sample
EUR 97.2
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM.

Compound 401

B7337-10 10 mg
EUR 268.8

Compound 401

B7337-25 25 mg
EUR 529.2

Compound 401

B7337-5 5 mg
EUR 216

Compound K

N1890-20 20 mg
EUR 408
Description: Compound K

Compound 2

HY-U00358 10mg
EUR 7249.2

Compound 34

GL2080-1MG 1 mg
EUR 447.6

Compound 34

GL2080-200UG 200 ug
EUR 199.2

Compound 112254

GL3740-10MG 10 mg
EUR 199.2

Compound 112254

GL3740-50MG 50 mg
EUR 550.8

Compound E

GL3746-1MG 1 mg
EUR 453.6

Compound E

GL3746-250UG 250 ug
EUR 206.4

Compound E

GL3746-5MG 5 mg
EUR 1197.6

Compound E

HY-14176 10mM/1mL
EUR 832.8

Compound 401

HY-19341 10mM/1mL
EUR 223.2

Imidazoquinoline Compound

VAdv-Ly0028 5 mg
EUR 3936
Description: Imidazoquinoline compound, a TLR7 agonist vaccine adjuvant.

Compound 112254

2573-25 each
EUR 705.6

Compound 112254

2573-5 each
EUR 222

Compound 401

1657-5 each
EUR 285.6

Compound 1

1688-5 each
EUR 248.4

Compound 34

1898-1000 each
EUR 548.4

Compound 34

1898-200 each
EUR 189.6

Compound E

1949-1000 each
EUR 444

Compound E

1949-250 each
EUR 183.6

Compound W

2208-250 each
EUR 360

Compound W

2208-50 each
EUR 138

Macitentan (n-butyl analogue)

HY-14184A 10mM/1mL
EUR 380.4

Analogue Control Fixed Speed

MIX1982 EACH
EUR 816.24

Clifton Blockheater Thermubloc Analogue

BLO1060 EACH
EUR 478.8

Ultrasonic Bath 2.5L Analogue

XUBA3 EACH
EUR 761.52

16kg Analogue Orbital shaker

SHA6088 EACH
EUR 1755.6

23kg Analogue Orbital Shaker

SHA6090 EACH
EUR 3123.6

ss-DNA (Single-stranded DNA Antibody IgG) ELISA test

51 96T/Box Ask for price
Description: ELISA based test for quantitative detection of ss-DNA (Single-stranded DNA Antibody IgG)

Roller Mixer 9 roll Analogue

MIX1984 EACH
EUR 991.8

Electrothermal MC227 Analogue Power Control

HEA5252 EACH
EUR 384.18

GPR120 Compound A

C5824-10 10 mg
EUR 351.6
Description: GPR120 Compound A is an orally active and high-affinity agonist of GPR120 [1].G-protein coupled receptor 120 is a G protein-coupled receptor which has been expressed in intestine, adipocytes, and pro-inflammatory macrophages that is activated by long chain free fatty acids.

GPR120 Compound A

C5824-5 5 mg
EUR 236.4
Description: GPR120 Compound A is an orally active and high-affinity agonist of GPR120 [1].G-protein coupled receptor 120 is a G protein-coupled receptor which has been expressed in intestine, adipocytes, and pro-inflammatory macrophages that is activated by long chain free fatty acids.

GPR120 Compound A

C5824-50 50 mg
EUR 1104
Description: GPR120 Compound A is an orally active and high-affinity agonist of GPR120 [1].G-protein coupled receptor 120 is a G protein-coupled receptor which has been expressed in intestine, adipocytes, and pro-inflammatory macrophages that is activated by long chain free fatty acids.

Dorsomorphin (Compound C)

B3252-10 10 mg
EUR 164.4
Description: Dorsomorphin is a cell-permeable and reversible ATP-competitive inhibitor of AMP-activated protein kinase (AMPK) with Ki value of 109nM [1].Dorsomorphin is highly selective against AMPK over other structure related kinases such as protein kinase A, protein kinase C and Janus kinase 3.

Dorsomorphin (Compound C)

B3252-5 5 mg
EUR 129.6
Description: Dorsomorphin is a cell-permeable and reversible ATP-competitive inhibitor of AMP-activated protein kinase (AMPK) with Ki value of 109nM [1].Dorsomorphin is highly selective against AMPK over other structure related kinases such as protein kinase A, protein kinase C and Janus kinase 3.

Dorsomorphin (Compound C)

B3252-50 50 mg
EUR 408
Description: Dorsomorphin is a cell-permeable and reversible ATP-competitive inhibitor of AMP-activated protein kinase (AMPK) with Ki value of 109nM [1].Dorsomorphin is highly selective against AMPK over other structure related kinases such as protein kinase A, protein kinase C and Janus kinase 3.

Teijin compound 1

B5468-10 10 mg
EUR 466.8

Teijin compound 1

B5468-50 50 mg
EUR 1771.2

Antiasthmatic Compound 1

HY-U00409 1mg
EUR 1018.8

Compound 112254 hydrochloride

GL8859-10MG 10 mg
EUR 199.2

Compound 112254 hydrochloride

GL8859-50MG 50 mg
EUR 550.8

Antibacterial compound 2

HY-101730 5mg
EUR 9580.8

Antibacterial compound 1

HY-101819 5mg
EUR 2637.6

Teijin compound 1

HY-108323 5mg
EUR 374.4

APHA Compound 8

M45003 1 mg
EUR 341.88

NCH 51

A4495-10 10 mg
EUR 277.2
Description: NCH 51 is a potent and novel inhibitor of histone deacetylase [1]. Histone deacetylases (HADC) are a series of enzymes that remove acetyl groups from an ?-N-acetyl lysine amino acid on a histone and make the histones to wrap the DNA more tightly, which prevent transcription.

NCH 51

A4495-5.1 10 mM (in 1mL DMSO)
EUR 240
Description: NCH 51 is a potent and novel inhibitor of histone deacetylase [1]. Histone deacetylases (HADC) are a series of enzymes that remove acetyl groups from an ?-N-acetyl lysine amino acid on a histone and make the histones to wrap the DNA more tightly, which prevent transcription.

NCH 51

A4495-50 50 mg
EUR 1028.4
Description: NCH 51 is a potent and novel inhibitor of histone deacetylase [1]. Histone deacetylases (HADC) are a series of enzymes that remove acetyl groups from an ?-N-acetyl lysine amino acid on a histone and make the histones to wrap the DNA more tightly, which prevent transcription.

Ro 51

B5572-10 10 mg
EUR 466.8

Ro 51

B5572-50 50 mg
EUR 1771.2

NCH 51

B1130-25 each
EUR 548.4

NCH 51

B1130-5 each
EUR 183.6

8-hydroxy Guanosine, compound

8OHG15-N-1 1 mg
EUR 242.4

8-hydroxy Guanosine, compound

8OHG15-N-5 5 mg
EUR 708

PKM2 inhibitor(compound 3k)

B8217-25 25 mg
EUR 494.4

PKM2 inhibitor(compound 3k)

B8217-5 5 mg
EUR 201.6

DiscoveryProbe? Bioactive Compound Library

L1022-.1 100 uL/well(10 mM solution)
EUR 28066.8

DiscoveryProbe? Bioactive Compound Library

L1022-.25 250 uL/well(10 mM solution)
EUR 50450.4

DiscoveryProbe? Bioactive Compound Library

L1022-5 5 mg/well
EUR 65623.2

DiscoveryProbe? GPCR Compound Library

L1025-.1 100 uL/well(10 mM solution)
EUR 5683.2

DiscoveryProbe? GPCR Compound Library

L1025-.25 250 uL/well(10 mM solution)
EUR 10221.6

DiscoveryProbe? GPCR Compound Library

L1025-5 5 mg/well
EUR 13284

DiscoveryProbe? Epigenetics Compound Library

L1029-.1 100 uL/well(10 mM solution)
EUR 7144.8

DiscoveryProbe? Epigenetics Compound Library

L1029-.25 250 uL/well(10 mM solution)
EUR 12866.4

DiscoveryProbe? Epigenetics Compound Library

L1029-5 5 mg/well
EUR 16764

DiscoveryProbe? Autophagy Compound Library

L1031-.1 100 uL/well(10 mM solution)
EUR 13408.8

DiscoveryProbe? Autophagy Compound Library

L1031-.25 250 uL/well(10 mM solution)
EUR 24141.6

DiscoveryProbe? Autophagy Compound Library

L1031-5 5 mg/well
EUR 31380

DiscoveryProbe? Apoptosis Compound Library

L1036-.1 100 uL/well(10 mM solution)
EUR 4166.4

DiscoveryProbe? Apoptosis Compound Library

L1036-.25 250 uL/well(10 mM solution)
EUR 7437.6

DiscoveryProbe? Apoptosis Compound Library

L1036-5 5 mg/well
EUR 9664.8

Cancer-Targeting Compound 1

HY-U00300 1mg
EUR 1018.8

Neuromuscular-targeting compound 1

HY-U00310 20mg
EUR 5763.6

Itch-Targeting Compound 1

HY-U00361 20mg
EUR 13416

Arrhythmic-Targeting Compound 1

HY-U00393 5mg
EUR 11233.2

Asthma relating compound 1

HY-U00412 5mg
EUR 3415.2

Arrhythmias-Targeting Compound 1

HY-101750 20mg
EUR 6819.6

NPS ALX Compound 4a

HY-103090 5mg
EUR 349.2

Horsley Compound Action Angled

INS6130 EACH
EUR 242.82

CCT251545 Analogue, Compound 51